Literature DB >> 944163

Diurnal variation in blood sugar and serum insulin in response to glucose and/or glucagon in healthy subjects.

F Melani, A Verrillo, M Marasco, A Rivellese, J Osorio, M G Bertolini.   

Abstract

The role of insulin secretion in the diurnal variation of glucose tolerance has been investigated. In ten healthy subjects, at 08.00 and at 18.00 after 10 hrs of fasting, a combination test of glucose and glucagon was performed. 1 mg glucagon was injected intravenously 40 min after the intravenous infusion of glucose (0.5 g/kg b.w.). Samples for blood sugar (BS) and serum immunoreactive insulin (IRI) were taken before and 2-5 min following the glucose and glucagon loads, and thereafter at 10 min intervals up to 85 min. In the afternoon test, the mean blood sugar values were higher, the differences in the 20-85 min values being statistically significant: the IRI values were statistically lower after glucose, while after glucagon, the increase of serum IRI was apparently similar in both morning and afternoon tests. However, the insulin/glucose ratio (I/G) was significantly lower at 18.00 at 55-85 men. Corresponding results were obtained in six additional healthy subjects when only glucagon (1 mg i.v.) was injected. In this case also, the mean insulin levels were lower in the afternoon after 5 min, while the BS values during the maximal insulin release (2-30 min) were comparable in both the morning and afternoon tests. In the 40-60 min interval, the BS levels were significantly higher in the afternoon. The existence of a diurnal variation in the blood sugar after intravenous glucose load, as well as after glucagon, seems to be correlated to a simultaneous diurnal variation in the insulin response, suggesting decreased pancreatic beta-cell activity in the afternoon.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 944163     DOI: 10.1055/s-0028-1095597

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  4 in total

1.  The role of insulin-resistance and free fatty acids on diurnal variations in glucose response to glucagon stimulation.

Authors:  A Ciavarella; M Flammini; M Spoto; M Capelli; V Galuppi; P Vannini
Journal:  J Endocrinol Invest       Date:  1982 Nov-Dec       Impact factor: 4.256

Review 2.  Circadian regulation of glucose, lipid, and energy metabolism in humans.

Authors:  Eleonora Poggiogalle; Humaira Jamshed; Courtney M Peterson
Journal:  Metabolism       Date:  2018-01-09       Impact factor: 8.694

Review 3.  Circadian rhythms and metabolic syndrome: from experimental genetics to human disease.

Authors:  Eleonore Maury; Kathryn Moynihan Ramsey; Joseph Bass
Journal:  Circ Res       Date:  2010-02-19       Impact factor: 17.367

4.  Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers.

Authors:  Namyi Gu; Min Kyu Park; Tae-Eun Kim; Mi Young Bahng; Kyoung Soo Lim; Sang-Heon Cho; Seo Hyun Yoon; Joo-Youn Cho; In-Jin Jang; Kyung-Sang Yu
Journal:  Drug Des Devel Ther       Date:  2014-10-06       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.